- Companies
- Alira Health
Alira Health Funding, Investors & Competitors
Alira Health has raised $133M across 3 funding rounds, most recently a $58M undisclosed-stage round in January 2023.
Last Alira Health funding round
$58M
Undisclosed stage · Jan 2023
Cumulative funding Alira Health raised
$133M
across 3 funding rounds
Key investors in Alira Health
Creadev
About Alira Health
Alira Health is a Boston-headquartered international advisory firm offering strategy, innovation, and investment services for healthcare and life sciences. Teams of strategists, bankers, physicians, and scientists address clinical, operational, digital, and financial challenges via alirahealth.com.
Founded
1999
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Services
Alira Health Funding History
Alira Health has raised a total of $133M across 3 funding rounds.
Alira Health's first fundraising round was a $35M undisclosed-stage round in April 2021. The most recent completed round was a $58M undisclosed-stage round in January 2023.
Alira Health funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jan 2023 | Undisclosed stage | - | $58M | Alira Health is a global healthcare advisory, clinical research, and technology company focused on humanizing healthcare through patient-centric solutions, innovative technologies, and services spanning development to medical care for pharma, biotech, and medtech clients. In January 2023, the company secured an additional $58 million in capital funding to accelerate global growth and delivery of technology-enabled healthcare solutions, building on prior raises of $35 million in 2021 and $40 million in 2022 led by Creadev. The $58 million investment positions Alira Health to capitalize on U.S. federal rules under the Cures Act enabling patient access to electronic health information, supporting strategies for collecting clinical and real-world data directly from patients to inform drug and device development. Later, in December 2024, Alira Health raised up to $100 million in growth debt from Symbiotic Capital to drive strategic expansion, enhance technology platforms, and scale global operations under new COO Andrea Pulvirenti. Alira Health's activities include market reports on medtech contract manufacturing and private equity deals in healthcare, highlighting industry trends such as VC investments and M&A multiples. |
| Jan 2022 | Undisclosed stage | Creadev (lead) | $40M | Alira Health is a global technology-enabled healthcare consultancy focused on humanizing healthcare through patient-centric solutions, offering services from development to medical care for pharma, biotech, medtech clients, including research, clinical development, technology-powered consulting, and real-world evidence. On January 13, 2022, the company closed an equity financing raising $40 million in gross proceeds led by existing investor Creadev, backed by the Mulliez family of France. The funds were intended to invest in solutions that actively engage patients in service delivery for healthcare providers, payers, and suppliers, positioning Alira Health to lead in using patient-provided data on digital health platforms to inform product lifecycles. CEO Gabriele Brambilla emphasized the investor support for their mission to put patients at the center of healthcare transformation. Creadev's Healthcare Managing Director Yohann Gbahoué praised Alira Health's strategy, growth, vision of patient-centric innovation, and transformational acquisitions, committing to support further organic and inorganic growth. This round followed a $35 million financing in April 2021 also led by Creadev and preceded a $58 million capital injection in January 2023 from existing investors. Alira Health, based in Framingham, Massachusetts, operates internationally with a focus on merging pharmaceutical, medical, and digital technologies through a patient-centric approach. Later developments included a growth debt facility of up to $100 million from Symbiotic Capital to enhance technology platforms and scale global presence, along with appointing a COO. The company leverages trends like the U.S. Cures Act enabling patient access to electronic health information to advance data collection for drug and device development. |
| Apr 2021 | Undisclosed stage | Creadev (lead) | $35M | Alira Health is a global technology-enabled healthcare consultancy and advisory firm focused on advancing healthcare and life sciences through patient-centric solutions that integrate pharmaceutical, medical, and digital technologies. Founded in 1999 and based in Framingham, Massachusetts, the company advises pharmaceutical, biotech, and medtech clients on product development, regulatory issues, and clinical trials, while developing tech-enabled platforms to engage patients and collect real-world data. On April 12, 2021, Alira Health closed a $35 million equity financing round led by Creadev, an evergreen investment firm backed by the French Mulliez family, to accelerate its growth strategy. This 2021 round was followed by additional funding, including a $40 million round in January 2022 also led by Creadev, and a $58 million capital injection in January 2023, bringing total funds raised to $133 million across multiple rounds. The funds have been directed toward enhancing patient engagement solutions, scaling technology platforms, and capitalizing on opportunities like the 21st Century Cures Act, which facilitates patient access to electronic health information. Alira Health positions itself to inform drug and device development through patient-collected clinical data. Creadev, with offices in Paris, New York, Shanghai, and Nairobi, has invested over €1.8 billion since 2002 in companies scaling in healthcare and other essential sectors. Later developments include a growth debt facility of up to $100 million from Symbiotic Capital in December 2024 and the appointment of a COO to support global expansion. |
Who has invested in Alira Health?
1 investor has backed Alira Health across its funding rounds, including Creadev.
Lead investors include Creadev.
Alira Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 Alira Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Alira Health
Alira Health has acquired 10 companies to date.
Last acquisition by Alira Health was on September 6th 2022. Alira Health acquired Artisan Healthcare Consulting for undisclosed valuation.
Latest Acquisitions by Alira Health
| Description | Artisan Healthcare Consulting is a specialized firm delivering business development and branding strategies tailored for healthcare organizations. Operating from its base in the United States, the company assists hospitals, clinics, and medical practices in expanding market presence through targeted growth initiatives and visual identity enhancements. Services encompass market analysis, competitive positioning, and digital marketing campaigns designed to boost patient acquisition and retention in competitive sectors. | RedCrow is a Salt Lake City-headquartered equity crowdfunding platform enabling accredited and non-accredited investors to fund startups under Regulation Crowdfunding. The site hosts 200 campaigns annually, raising over $50 million since 2016 for biotech, cleantech, and software firms. RedCrow's Discovery process screens deals via its investment committee and community votes before listing on the primary marketplace. | Sourcia is a contract research organization specializing in clinical trials from Phase I to IV for biotech and medical device firms. Lyon-based in France, the company was founded in 2012 and concentrates on European markets with expertise in CE marking studies. Sourcia manages full-service trials including site selection, patient recruitment, and regulatory submissions, supporting over 30 studies annually across therapeutic areas like oncology and cardiology. The firm employs 50 professionals to deliver compliant data for small to mid-sized innovators. | Self Care Catalysts is a company shifting power to patients through better insights and data. Funded by Prosoft Development Inc. with offices in MaRS Discovery District Toronto and San Francisco. Supported by Springboard Enterprises, CTA Philadelphia and San Francisco, Rick Hansen Institute, and Community Matters Toronto. | |
| HQ Country | |||||
| HQ City | Boston, MA | San Francisco, CA | Breda | Toronto | |
| Deal Date | 6 Sep 2022 | 11 May 2022 | 5 Apr 2022 | 25 Jan 2022 | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Alira Health acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Alira Health Competitors
Alira Health competitors include listed companies like Experian, Equifax, Gartner and Ipsos, and private ones like Mu Sigma and Sutherland.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $8.4B | $3B | $33B | 4.4x | ||
| Publicly listed | $6.1B | $1.8B | $19B | 3.7x | ||
| Publicly listed | $6.5B | $1.2B | $12B | 2.1x | ||
| Publicly listed | $2.9B | $429M | $1.7B | 0.7x | ||
| Private | $200M | - | $1.5B | 7.5x | ||
| Private | - | - | $1B | - |
Alira Health Public Comps
Alira Health is still privately-owned, but its public comps include Accenture, RELX, Thomson Reuters, HCLTech, Experian, Cognizant, Verisk Analytics, Capgemini, Equifax and Nomura Research Institute.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $70B | $12B | 1.7x | 1.6x | 10.1x | 8.4x | |||
| $13B | $4.9B | 5.5x | 5.3x | 14.4x | 13.2x | |||
| $7.5B | $3B | 6.1x | 5.8x | 15.3x | 14.5x | |||
| $14B | $2.7B | 2.4x | 2.3x | 12.2x | 11.1x | |||
| $8.4B | $3B | 4.5x | 4.4x | 12.7x | 12.1x | |||
| $21B | $4B | 1.4x | 1.3x | 7.3x | 7.2x | |||
| $3.1B | $1.7B | 8.8x | 8.5x | 16.2x | 15.1x | |||
| $26B | $3.4B | 1.1x | 1.1x | 8.6x | 6.8x | |||
This data is available for Pro users. Sign up to see all Alira Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Alira Health
| When was Alira Health founded? | Alira Health was founded in 1999. |
| Where is Alira Health headquartered? | Alira Health is headquartered in Paris, France. |
| Is Alira Health publicly listed? | No, Alira Health is a private, VC-backed company. |
| How much funding has Alira Health raised? | Alira Health has raised $133M across 3 funding rounds. |
| What was Alira Health's last funding round? | Alira Health's last funding round was a $58M undisclosed-stage round in January 2023. |
| Who are Alira Health's investors? | Alira Health's investors include Creadev. |
| Which companies are comparable to Alira Health? | Companies comparable to Alira Health include Experian, Equifax, Gartner, Ipsos, Mu Sigma and Sutherland. |
| How many companies has Alira Health acquired? | Alira Health has acquired 10 companies, including Artisan Healthcare Consulting, RedCrow, Sourcia, Self Care Catalysts and PatchAi. |
See companies similar to Alira Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




